or Try an Advanced Search...

    Technical Analysis for CRSP - CRISPR Therapeutics AG

    Grade Last Price % Change Price Change
    F 55.72 -2.18% -1.24
    CRSP closed up 2.24 percent on Wednesday, May 15, 2024, on approximately normal volume.
    Earnings due: May 30
    *** please verify all earnings dates ***
    11 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical CRSP trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.18%
    Bollinger Band Squeeze Range Contraction -2.18%
    BB Squeeze + Upper Band Touch Range Contraction -2.18%
    Inside Day Range Contraction -2.18%
    Gapped Up Strength -2.18%
    Up 3 Days in a Row Strength -2.18%
    Upper Bollinger Band Touch Strength -2.18%
    Pocket Pivot Bullish Swing Setup 0.02%
    Bollinger Band Squeeze Range Contraction 0.02%
    BB Squeeze + Upper Band Touch Range Contraction 0.02%
    Older End-of-Day Signals for CRSP ...

       Recent Intraday Alerts

    Alert Time
    Down 2 % about 5 hours ago
    60 Minute Opening Range Breakdown about 5 hours ago
    Non-ADX 1,2,3,4 Bearish Retracement Entry about 5 hours ago
    Fell Below Previous Day's Low about 5 hours ago
    Down 1% about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    CRSP Chart by TradingView
    Basic chart:

    Profile

    Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9

    Is CRSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)
    May 15 Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
    May 14 2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
    May 13 15 Best ARK Stocks To Buy Now
    May 13 Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
    May 11 Broker Revenue Forecasts For CRISPR Therapeutics AG (NASDAQ:CRSP) Are Surging Higher
    May 10 CRISPR Therapeutics AG Reports Q1 2024 Earnings: Misses Analyst Net Income Forecast
    May 10 We're Interested To See How CRISPR Therapeutics (NASDAQ:CRSP) Uses Its Cash Hoard To Grow
    May 9 Bluebird bio spikes even as CRISPR leads in gene therapy rollout
    May 9 CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
    See more CRSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 91.1
    52 Week Low 37.55
    Average Volume 1,368,684
    200-Day Moving Average 59.31
    50-Day Moving Average 63.29
    20-Day Moving Average 54.90
    10-Day Moving Average 54.99
    Average True Range 3.01
    RSI (14) 48.45
    ADX 22.15
    +DI 21.58
    -DI 19.48
    Chandelier Exit (Long, 3 ATRs) 50.13
    Chandelier Exit (Short, 3 ATRs) 60.06
    Upper Bollinger Bands 57.81
    Lower Bollinger Band 52.00
    Percent B (%b) 0.85
    BandWidth 10.57
    MACD Line -2.10
    MACD Signal Line -2.88
    MACD Histogram 0.783
    Fundamentals Value
    Market Cap 4.52 Billion
    Num Shares 79.4 Million
    EPS -4.47
    Price-to-Earnings (P/E) Ratio -12.74
    Price-to-Sales 34.65
    Price-to-Book 3.22
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 60.50
    Resistance 3 (R3) 60.70 59.73 59.91
    Resistance 2 (R2) 59.73 58.83 59.63 59.71
    Resistance 1 (R1) 58.34 58.27 57.86 58.14 59.52
    Pivot Point 57.37 57.37 57.12 57.27 57.37
    Support 1 (S1) 55.98 56.47 55.50 55.78 54.40
    Support 2 (S2) 55.01 55.91 54.91 54.21
    Support 3 (S3) 53.62 55.01 54.01
    Support 4 (S4) 53.42